Industry Report: Global Traceability and Serialisation in Pharma

06 June 2014

Counterfeit pharmaceuticals pose a significant threat to the viability of the pharmaceutical industry and patient safety. As supply chains become more complex and multidimensional the challenge of tracking products through the supply chain increases. Pharmaceuticals consistently rank within the top ten categories for counterfeit goods and the risk to products can vary from country to country. In response pharmaceutical manufacturers are investing more in product security initiatives.
In this industry report the results of the latest Pharmaceutical Serialisation & Traceability 2014 Survey are presented, providing expert insight and analysis from key opinion leaders in the field (Pharma IQ).
Click here for more information about the report.
Click here to download the report (1.43 MB).

This item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.